IFIT3 overexpression is correlated with advanced tumor-node-metastasis stage, lymph node metastasis, and poor prognosis in patients with LUSC and LCLC. The gene discussed is IFIT3; the disease is metastatic malignant neoplasm in the lymph nodes.